Verition Fund Management
NVCR icon

Verition Fund Management’s NovoCure NVCR Stock Holding History

Verition Fund Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-168,873
Closed -$2.18M – 3156
2025
Q4 		$2.18M Buy
168,873
+73,668
+77% +$946K 0.01% 1527
2025
Q3 		$1.23M Buy
95,205
+55,898
+142% +$747K 0.01% 2366
2025
Q2 		$700K Buy
39,307
+750
+2% +$13.1K ﹤0.01% 2725
2025
Q1 		$687K Sell
38,557
-10,909
-22% -$248K ﹤0.01% 2375
2024
Q4 		$1.47M Buy
+49,466
New +$1.05M 0.01% 1767
2024
Q3 		– Sell
-85,108
Closed -$1.46M – 3423
2024
Q2 		$1.46M Buy
85,108
+38,325
+82% +$674K 0.01% 1450
2024
Q1 		$731K Buy
+46,783
New +$688K 0.01% 1798
2023
Q3 		– Sell
-10,663
Closed -$443K – 2572
2023
Q2 		$443K Buy
10,663
+2,490
+30% +$155K 0.01% 1310
2023
Q1 		$492K Buy
+8,173
New +$653K 0.01% 1247
2022
Q1 		– Sell
-3,188
Closed -$239K – 2928
2021
Q4 		$239K Buy
+3,188
New +$320K ﹤0.01% 2136
2021
Q3 		– Sell
-1,626
Closed -$361K – 2192
2021
Q2 		$361K Buy
+1,626
New +$316K ﹤0.01% 1252
2020
Q3 		– Sell
-9,034
Closed -$536K – 1285
2020
Q2 		$536K Buy
+9,034
New +$594K 0.02% 582
2020
Q1 		– Sell
-3,619
Closed -$305K – 918
2019
Q4 		$305K Sell
3,619
-521
-13% -$42.1K 0.01% 818
2019
Q3 		$310K Buy
+4,140
New +$331K 0.01% 797
2019
Q2 		– Sell
-6,436
Closed -$310K – 1275
2019
Q1 		$310K Buy
+6,436
New +$310K 0.01% 821

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Verition Fund Management's NVCR Position: Q1 2026 in Review

Verition Fund Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 168,873 shares — an estimated $2.18M sold.

Verition Fund Management first reported a position in NVCR in Q1 2019 and held it in 15 quarters. The position peaked at $2.18M in Q4 2025. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Verition Fund Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 168,873 NovoCure shares in Q1 2026, an estimated $2.18M.
  • Verition Fund Management first reported a position in NovoCure in Q1 2019 and held it in 15 quarters.
  • Verition Fund Management's NovoCure position peaked at $2.18M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.